Clinical Paper Request
The following papers have been published. To request a copy of the paper, please click on the title which
Siltuximab for multicentric Castleman’s disease: a randomised, double-blind, placebo-controlled trial. van Rhee F, Wong RS, Munshi N, Rossi JF, Ke XY, Fossa A, et al.
will send a request to EUSA Pharma medical information.
Lancet Oncol. 2014;15(9):966-74. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, et al.
Blood. 2017;129(12):1646-57. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.van Rhee F, Voorhees R, Dispenzieri A, Fosså A, Srkalovic G, Ide M, et al.
Blood. 2018;132(15): 2115-24.